
- We need to connect more data points (pre-, perioperative, and post-operative) that can be used to improve efficiency and quality of care.
- We need to connect more stakeholders. We have a multitude of new stakeholders entering the picture. We are not only talking about surgeons and anesthesiologists, we are also talking about OR management, the c-suite of the hospital, payers, insurance companies, medical malpractice companies, and of course, medical device companies, coming together as a broader set of stakeholders that are both the providers of data and users of data; and very importantly the patient, who enters the picture both as a provider of data and recipient of information.
- The third element is a very important one: technologies and data storage that are procedure neutral and vendor-neutral,so no matter what surgical procedure is performed or who is performing it, which devices are used, that data needs to be captured.
In the last few years, we have seen the market demand for data-driven surgery growing tremendously. It is the future of surgery, a combination of surgical technology becoming more mature, more pressure on quality and efficiency, and a cultural mindset shift.
All of these factors have had a lot of buzz and attention, but it is only in the last few years that we have seen the market demand growing tremendously. It is a combination of surgical technology becoming more mature, more pressure on quality and efficiency, and a cultural mindset shift. There is a new generation of surgeons coming into the picture who are used to integrated devices and integrated platforms, so there is a lot of market demand and a lot of growth in this sector. Most surgical companies are excited about the potential of digital and there is a lot of investment flowing into this area.
Transformation Begins with Digital Enablement and Cooperation
For MedTech companies that are centered around making devices that have a core business selling consumables, it is very hard to transition to a software as a service (SaaS) model overnight. There is no surgical company that does it all and knows it all. The data platform approach includes pre- and post-operative surgical data as well, which is something that those companies have very little exposure to and very little experience in. In their core business or their core therapeutic areas, they are the specialists, and they should remain as specialists and build out their therapeutic areas both physically and digitally. Then there needs to be another layer of companies and solutions to capture the metadata and longitudinal data; not as a replacement model, but one centered around digital enablement and collaboration, similar to what Johnson & Johnson have done with Microsoft.
Caresyntax has ongoing partnerships with large data companies and large medical device companies and we really see the synergies of the ecosystem approach playing out to the favor of both parties: the established medical device companies and the new data layer companies that are focusing on surgery.
Surgeons have been wanting data-driven solutions for a long time. They are performance-oriented, almost like high-performance athletes, and the majority of surgeons want to improve their skills, they want to deliver better outcomes, but until now they have lacked the OR technology tools for that.
One of the most important steps that Caresyntax took early on was to talk to insurance companies and bring onboard large health insurers—as well as reinsurers, and risk insurers—to help find and help design the solution in a way that has been beneficial for them as well.
Overcoming the Surgical Technology Budget Hurdle
One of the main hurdles to the adoption of integrated technology is the budgets within hospitals and the availability of financing for this kind of solution. As a result, we have looked to the payors and the risk-bearing entities because they benefit from better outcomes and the healthier population that they insure. One of the most important steps that Caresyntax took early on in the journey was to talk to insurance companies and bring onboard large health insurers–as well as reinsurers, and risk insurers–to help find and help design the solution in a way that has been beneficial for them as well. It has provided a growth moment for the company where we can come into a hospital and offer not only the tech but also a financing solution.
See How Caresyntax Can Help Your Business
Learn MoreRelated articles

9 Advantages Of Open Ecosystems In Healthcare
April 14, 2026·5 min read
.png&w=828&q=75)
The Equipment Delay Hospitals Don't Budget For, But Ultimately Pay For
March 27, 2026·5 min read

The Hidden Operational Cost of OR Staffing Shortages and How to Reduce It
February 11, 2026·5 min read